Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescence Imaging Evaluation of Rheumatoid Arthritis Synovitis Using Indocyanine Green
jRCTs051250097Not yet recruiting
- Sponsor
- Shimadzu Corporation
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of indocyanine green in rheumatoid arthritis (RA) and hand osteoarthritis (3 cohorts), sponsored by Shimadzu Corporation. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
indocyanine green
03
Conditions
rheumatoid arthritis (RA)hand osteoarthritis
Beyond the preview
Go deeper on jRCTs051250097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250097.